229 related articles for article (PubMed ID: 23830984)
1. Diethylstilbestrol induces vaginal adenosis by disrupting SMAD/RUNX1-mediated cell fate decision in the Müllerian duct epithelium.
Laronda MM; Unno K; Ishi K; Serna VA; Butler LM; Mills AA; Orvis GD; Behringer RR; Deng C; Sinha S; Kurita T
Dev Biol; 2013 Sep; 381(1):5-16. PubMed ID: 23830984
[TBL] [Abstract][Full Text] [Related]
2. SIX1 cooperates with RUNX1 and SMAD4 in cell fate commitment of Müllerian duct epithelium.
Terakawa J; Serna VA; Nair DM; Sato S; Kawakami K; Radovick S; Maire P; Kurita T
Cell Death Differ; 2020 Dec; 27(12):3307-3320. PubMed ID: 32572167
[TBL] [Abstract][Full Text] [Related]
3. Roles of p63 in the diethylstilbestrol-induced cervicovaginal adenosis.
Kurita T; Mills AA; Cunha GR
Development; 2004 Apr; 131(7):1639-49. PubMed ID: 14998922
[TBL] [Abstract][Full Text] [Related]
4. FGFR2IIIb-MAPK Activity Is Required for Epithelial Cell Fate Decision in the Lower Müllerian Duct.
Terakawa J; Rocchi A; Serna VA; Bottinger EP; Graff JM; Kurita T
Mol Endocrinol; 2016 Jul; 30(7):783-95. PubMed ID: 27164167
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of p63 isoforms in female reproductive organs.
Kurita T; Cunha GR; Robboy SJ; Mills AA; Medina RT
Mech Dev; 2005 Sep; 122(9):1043-55. PubMed ID: 15922574
[TBL] [Abstract][Full Text] [Related]
6. Morphological effects of diethylstilbestrol on neonatal mouse uterus and vagina.
Plapinger L
Cancer Res; 1981 Nov; 41(11 Pt 1):4667-77. PubMed ID: 7306983
[TBL] [Abstract][Full Text] [Related]
7. The development of cervical and vaginal adenosis as a result of diethylstilbestrol exposure in utero.
Laronda MM; Unno K; Butler LM; Kurita T
Differentiation; 2012 Oct; 84(3):252-60. PubMed ID: 22682699
[TBL] [Abstract][Full Text] [Related]
8. Involvement of activin signaling in abnormalities of mouse vagina exposed neonatally to diethylstilbestrol.
Nakajima T; Iguchi T; Sato T
Cell Tissue Res; 2011 Jun; 344(3):527-38. PubMed ID: 21509459
[TBL] [Abstract][Full Text] [Related]
9. The embryologic development of the human vagina.
Ulfelder H; Robboy SJ
Am J Obstet Gynecol; 1976 Dec; 126(7):769-76. PubMed ID: 1033667
[TBL] [Abstract][Full Text] [Related]
10. Vaginal adenosis and adenocarcinoma in mice exposed prenatally or neonatally to diethylstilbestrol.
Newbold RR; McLachlan JA
Cancer Res; 1982 May; 42(5):2003-11. PubMed ID: 7066910
[TBL] [Abstract][Full Text] [Related]
11. Roles of p63 in differentiation of Müllerian duct epithelial cells.
Kurita T; Cunha GR
Ann N Y Acad Sci; 2001 Dec; 948():9-12. PubMed ID: 11795399
[TBL] [Abstract][Full Text] [Related]
12. Dysplasia and cytologic findings in 4,589 young women enrolled in diethylstilbestrol-adenosis (DESAD) project.
Robboy SJ; Szyfelbein WM; Goellner JR; Kaufman RH; Taft PD; Richard RM; Gaffey TA; Prat J; Virata R; Hatab PA; McGorray SP; Noller KL; Townsend D; Labarthe D; Barnes AB
Am J Obstet Gynecol; 1981 Jul; 140(5):579-86. PubMed ID: 7195652
[TBL] [Abstract][Full Text] [Related]
13. Vaginal bleeding and diethylstilbestrol exposure during pregnancy: relationship to genital tract clear cell adenocarcinoma and vaginal adenosis in daughters.
Sharp GB; Cole P
Am J Obstet Gynecol; 1990 Apr; 162(4):994-1001. PubMed ID: 2327468
[TBL] [Abstract][Full Text] [Related]
14. In utero exposure to DES. Evaluation and followup of 199 women.
Fowler WC; Edelman DA
Obstet Gynecol; 1978 Apr; 51(4):459-63. PubMed ID: 662229
[TBL] [Abstract][Full Text] [Related]
15. [Endocervical form of the vaginal adenosis (author's transl)].
Walz KA; Metzger H; Ludwig H
Arch Gynakol; 1978 Oct; 225(4):293-303. PubMed ID: 581443
[TBL] [Abstract][Full Text] [Related]
16. Vaginal adenosis in stillborns and neonates exposed to diethylstilbestrol and steroidal estrogens and progestins.
Johnson LD; Driscoll SG; Hertig AT; Cole PT; Nickerson RJ
Obstet Gynecol; 1979 Jun; 53(6):671-9. PubMed ID: 450333
[TBL] [Abstract][Full Text] [Related]
17. Postnatal vaginal nodules induced by prenatal diethylstilbestrol treatment correlate with later development of ovary-independent vaginal and uterine changes in mice.
Ozawa S; Iguchi T; Sawada K; Ohta Y; Takasugi N; Bern HA
Cancer Lett; 1991 Jul; 58(3):167-75. PubMed ID: 1855193
[TBL] [Abstract][Full Text] [Related]
18. MSX2 promotes vaginal epithelial differentiation and wolffian duct regression and dampens the vaginal response to diethylstilbestrol.
Yin Y; Lin C; Ma L
Mol Endocrinol; 2006 Jul; 20(7):1535-46. PubMed ID: 16513791
[TBL] [Abstract][Full Text] [Related]
19. The effects of local progesterone on stilbestrol-associated vaginal adenosis.
Herbst AL; Robboy SJ; Macdonald GJ; Scully E
Am J Obstet Gynecol; 1974 Mar; 118(5):607-15. PubMed ID: 4130676
[TBL] [Abstract][Full Text] [Related]
20. Management of the adolescent girl exposed in utero to DES.
Gerbie MV
Pediatr Ann; 1981 Dec; 10(12):23-6. PubMed ID: 7335401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
